In May 2026, Dexcom disclosed FDA-enforced, Class II voluntary recalls of its G7 and ONE/ONE+ iOS and watchOS apps worldwide due to a software defect that can delay or replay glucose readings and ...
In the lead-up to the American Diabetes Association’s Scientific Sessions, Dexcom announced an acquisition and Insulet rolled ...
For those in the diabetes community who’ve dreamed about seeing their in-the-moment blood sugar readings and trend data right on their smartwatch or bike computer while exercising, Dexcom and Garmin ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) and Companion Medical, Inc. today announced a collaboration to enable a direct exchange of CGM data from Dexcom with insulin data from InPen™ ...
Dexcom (DXCM) is leveraging AI to drive operational efficiency and product innovation, positioning itself as a platform medical provider in CGM. DXCM achieved 300 basis points in operating margin ...
Cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with glucose monitoring specialist Dexcom to integrate glucose data from the Dexcom G7 into its ...
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, today announced the availability of enhanced data sharing features for physician and patient users of the ...
Dexcom and DreaMed Diabetes Announce Collaboration to Integrate Dexcom CGM Data into DreaMed Advisor
TEL AVIV, Israel--(BUSINESS WIRE)--DreaMed Diabetes Ltd., the developer of personalized diabetes management solutions, and DexCom Inc., the leader in continuous glucose monitoring (CGM) for people ...
Dexcom, the San Diego medical device maker of continuous glucose monitoring systems, and digital health company Livongo announced a partnership Monday that aims to bring Type 1 diabetes patients into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results